Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Econex Biomedical is a clinical-stage medical device company dedicated to reducing the risk of stroke and embolic events during structural heart procedures. The company's primary focus is the development of the Econex Embolic Protection System, a specialized filter designed for use during Transcatheter Aortic Valve Replacement (TAVR). By capturing and removing embolic debris before it reaches the brain, Econex aims to enhance the safety profile of minimally invasive cardiac interventions. The device is engineered for ease of use and compatibility with standard clinical workflows, aiming to provide complete cerebral protection without interfering with valve delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Econex Biomedical.